Skip to content

Prophylactic Closed Incision Negative Pressure Wound Therapy on Abdominal Wounds - Clinical and Economic Perspectives

Prophylactic Closed Incision Negative Pressure Wound Therapy on Abdominal Wounds - Clinical and Economic Perspectives: A Multi-centre Randomised Trial

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04110353
Acronym
ProNounCE
Enrollment
0
Registered
2019-10-01
Start date
2020-06-30
Completion date
2022-06-30
Last updated
2023-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical Incision, Surgical Site Infection, Surgical Wound, Wound Infection

Keywords

Surgical Site infections, Negative Pressure Wound Therapy, Contaminated abdominal wounds, Closed incision abdominal wound, Prophylactic therapy

Brief summary

This study evaluates whether specialist negative pressure dressings reduce the risk of wound infections after operations when compared to conservative dressings, and if one negative pressure dressings works better than another. The study will look at patients who have had an open operation on their bowel and the wound closed at the end of the operation.

Detailed description

Surgical site infections (SSI) can affect up 41% of patients post-operatively. They are associated with significant healthcare and patient costs, and increased patient morbidity and mortality. Specialist post operative dressings with negative pressure wound therapy are available, and the WHO do recommended for use in high risk wounds, taking resources into account. However no further recommendations are available. This study will explore the rate of post-operative wound infections in adult patients undergoing open abdominal surgery on the bowel, and compare the rate of wound infections in these patients in relation to three different dressing types used after their operation. The study aims to determine if any of the dressings used within the study are associated with lower post-operative wound infection rates, and compare the overall costs of using each dressing type, including both direct healthcare costs and societal costs. Finally, it will evaluate participant's quality of life outcomes after open abdominal surgery, specifically relating to their wound.

Interventions

OTHERWound dressings: Conservative dressings

Conservative dressings to be placed on closed wounds post operatively, after open operations on the bowel. To be changed at day 7 or sooner if clinically indicated.

OTHERWound dressings: Prevena dressings

Prevena dressing to be placed on closed wounds post operatively, after open operations on the bowel. To be changed at day 7 or sooner if clinically indicated.

OTHERWound dressings: ciVAC dressings

Closed incision VAC dressings to be placed on closed wounds post operatively, after open operations on the bowel. To be changed at day 7 or sooner if clinically indicated.

Sponsors

Imperial College London
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Intervention model description

Stepped wedge design with randomisation at the level of the Hospitals not individual patients

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Emergency, trauma or elective contaminated abdominal operations within general surgery and/or colorectal surgery * Abdominal wounds closed at time of operation and expected to heal by primary intention * Patients who have the capacity to consent * To include complex abdominal wounds with existing infection where wounds have been closed and expected to heal by primary intention * To including graft or flap sites as part of general surgical procedure * Patients who are able to complete questionnaires post operatively, either alone or with assistance

Exclusion criteria

* Wounds where an appropriate seal cannot be obtained * Wounds left open and expected to heal by secondary intention * Patients known to have allergy or sensitivity to dressings being used * Patients who lack the capacity to consent

Design outcomes

Primary

MeasureTime frameDescription
Surgical Site InfectionUp to day 90The occurrence of surgical site infections at the post-operative wound and timeframe of occurrence

Secondary

MeasureTime frameDescription
Length of stayUp to 90 daysLength of stay post-operatively
Number of additional interventions received by participants due to development of a Surgical Site InfectionWithin 30 daysNeed for intervention or treatment for surgical site infection (antibiotics, opening up of wound at bedside, operative or radiological intervention)
Microscopy, culture and sensitivity results from swabs of any Surgical Site InfectionsWithin 30 daysCulture results if SSI post-operative (including sensitivities)
Post operative complications - otherWithin 30 daysOccurrence of other post-operative complications
Number of adverse reactions to treatments for Surgical Site InfectionsWithin 30 daysAdverse reactions to antibiotics given or to dressings use
Wound dressings - use ofUp to day 30-40Time to discontinuation of dressings, type and number of dressings used
Wound assessments - clinical assessment of presence of wound complication and healingAt day 7 (on removal of dressing), up to day 30 (on discharge), day 40 (at outpatient follow up)Independent blind assessment of wounds at day 7 post operatively, on discharge and at outpatient follow up, via wound photographs taken, and correlation with assessment by clinical team
Ninety day readmission rateUp to day 90Rate of readmission within 90 days
Cause of deathUp to day 90Cause of death for any mortalities within 90 days
Quality of life measures: EuroQol 5 Dimensions 5 Levels (EQ5D5L) questionnaireAt day 7 (on removal of dressing), up to day 30 (on discharge), day 40 (at outpatient follow up)Generic quality of life outcome measures using EQ5D5L questionnaire assessed at day 7 post operatively, on discharge and at outpatient follow up; individualised questions, no formal scale
Quality of life measures: Wound Quality of Life questionnairesAt day 7 (on removal of dressing), up to day 30 (on discharge), day 40 (at outpatient follow up)Wound specific quality of life outcome measures using Wound Quality of Life questionnaire assessed at day 7 post operatively, on discharge and at outpatient follow up; scales - not at all/a little/moderately/quite a lot/very much
Quality of life and economic measures: Economic assessment questionnaireAt day 40Assessment of economic impact of wound using single Economic questionnaire to be assessed at day 40; individualised questions that will be assessed, no formal scale
Long term follow up - Hernia occurrenceAt 1, 3 and 5 yearsDevelopment of incisional hernia
Ninety day mortality rateUp to day 90Mortality within 90 days

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026